Skip to content
  • English
  • French
Menu
  • About
    • Our Team
    • Commitment to Equity, Diversity, Inclusion & Indigeneity
  • Our Consortium
    • Clinical Trial Units
    • Research Networks
    • Portfolio Hospitals
  • Funded Projects
    • New Networks
    • Library
  • Meetings
  • Resources
    • Education
    • Patient Engagement
    • Community Hospital Resources
  • Contact
  • Calls to Action
  • gDSSA

KM RFA Announcement

The Accelerating Clinical Trials (ACT) Consortium recently held a competition for ACT Network members to support innovative knowledge mobilization practices.

Read More

RFA 5 Announcement

The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were

Read More

Group Selected to Run Pan-Canadian Single Research Ethics Board Review Process

International review panel selects CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with

Read More

Canadian Biotech Opportunity

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we

Read More

New Pan-Canadian Data and Sample Transfer Agreement

New pan-Canadian data and sample transfer agreement a game-changer for clinical research “We’ve built a high-speed legal highway for researchers

Read More

Upcoming Webinars

For more information about upcoming webinars, please see the ACT Education page! 

Read More

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.